Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

To improve patient quality of life and reduce health care costs, many conditions formerly thought to require inpatient care are now treated in the outpatient setting. Outpatient induction chemotherapy for acute myeloid leukemia (AML) may confer similar benefits. This possibility prompted a pilot stu...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood Adv
Главные авторы: Mabrey, Frances Linzee, Gardner, Kelda M., Shannon Dorcy, Kathleen, Perdue, Andrea, Smith, Heather A., Davis, Alicyn M., Hammer, Cody, Rizzuto, Donelle, Jones, Sunny, Quach, Kim, Scott, Bart L., Hendrie, Paul C., Percival, Mary-Elizabeth M., Walter, Roland B., Appelbaum, Frederick R., Estey, Elihu H., Becker, Pamela S.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2020
Предметы:
Clinical Trials and Observations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042997/
https://ncbi.nlm.nih.gov/pubmed/32074276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000707
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы